trial
as of 2026-07-01Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment
NCTId NCT00538122
at a glance
Phase — · Completed
Enrollment 12 (estimated)
Sponsored by Vanderbilt University Medical Center
Primary completion 2008-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
12 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2007-07
Primary completion
2008-07
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Vanderbilt University Medical CenterLead Sponsor
Eli Lilly and CompanyCollaborator
Investigators
1
Herbert Y Meltzer, M.D.Principal Investigator
Sites
1 total
Nashville, United States
Facts & assertions
4 sourced
Enrollment
12
Phase
NA
Primary Completion Date
2008-07
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
company
indication
investigator
person